LeuRS - Immune System Research

GSK3036656 is an orally active inhibitor of M. tuberculosis leucyl-tRNA synthetase

Edward Jenner 2022-06-25

Tuberculosis, one of the oldest known human diseases, is a potentially serious infectious disease that mainly affects the lungs. It is still one of the major causes of mortality since…

Bacterial

DS86760016 is a Potent Leucyl-tRNA Synthetase (LeuRS) Inhibitor

Edward Jenner 2020-08-12

Nosocomial infections can lead to mortality. They account for approximately 2 million patients per year in the United States. Gram-negative bacteria account for approximately two-thirds of nosocomial infections. Moreover, in…

GSK3036656 is an orally active inhibitor of M. tuberculosis leucyl-tRNA synthetase

DS86760016 is a Potent Leucyl-tRNA Synthetase (LeuRS) Inhibitor

You Missed

Mirikizumab is a Humanized IgG4 mAb for Ulcerative Colitis Research

Grazoprevir is a Hepatitis C virus NS3/4A Protease Inhibitor for Infection Research

Efbemalenograstim alfa is a Recombinant Fusion Protein for Neutropenia Research

Remibrutinib is an Orally Active BTK Inhibitor for Chronic Urticaria Research